Tissue macrophages comprise a heterogeneous group of cell types differing in location, surface markers and function 1 . Red pulp macrophages are a distinct splenic subset involved in removing senescent red blood cells 2 . Transcription factors such as PU.1 (also known as Sfpi1) and C/EBPa (Cebpa) have general roles in myelomonocytic development 3, 4 , but the transcriptional basis for producing tissue macrophage subsets remains unknown. Here we show that Spi-C (encoded by Spic), a PU.1-related transcription factor, selectively controls the development of red pulp macrophages. Spi-C is highly expressed in red pulp macrophages, but not monocytes, dendritic cells or other tissue macrophages. Spic 2/2 mice have a cell-autonomous defect in the development of red pulp macrophages that is corrected by retroviral Spi-C expression in bone marrow cells, but have normal monocyte and other macrophage subsets. Red pulp macrophages highly express genes involved in capturing circulating haemoglobin and in iron regulation. Spic 2/2 mice show normal trapping of red blood cells in the spleen, but fail to phagocytose these red blood cells efficiently, and develop an iron overload localized selectively to splenic red pulp. Thus, Spi-C controls development of red pulp macrophages required for red blood cell recycling and iron homeostasis.
Spi-C belongs to the Spi subfamily of Ets transcription factors, which includes PU.1 and Spi-B 5, 6 , and was initially reported to be expressed in B cells 5, 7 . We compared expression of PU.1, Spi-B and Spi-C across a panel of immune cells such as B cells, bone marrow monocytes, dendritic cells and several types of resident tissue macrophages, including red pulp macrophages (RPMs; Fig. 1a , Supplementary Fig. 1 ). PU.1 was broadly expressed and Spi-B was predominantly restricted to B cells 8, 9 . In contrast, Spi-C was highly expressed in RPMs, expressed at lower levels in B cells, and essentially absent in other cells. To test for a role of Spi-C in RPMs and B cells, we generated mice lacking Spic expression by gene targeting ( Supplementary Fig. 2 ). Male and female Spic 2/2 mice are fertile and healthy, with a normal lifespan, but are born at a somewhat lower than expected Mendelian frequency ( Supplementary Fig. 2 ). We also generated Spic null/null mice, in which the neomycin cassette was deleted from the targeted Spic allele ( Supplementary Fig. 2) .
RPMs have been defined as F4/80 hi CD68 1 CD11b lo/2 cells with strong autofluorescence 10, 11 . Both Spic 2/2 mice and Spic null/null mice showed a phenotype characterized by the selective loss of RPMs ( Fig. 1b and c, Supplementary Fig. 3a ), but showed no abnormalities in the development of B cells, conventional dendritic cells, plasmacytoid dendritic cells (Supplementary Figs 3 and 4, and Supplementary  Table 1 ) or T cells ( Supplementary Fig. 5 ), and had normal serum immunoglobulin levels ( Supplementary Fig. 4f ). We confirmed the loss of RPMs by immunohistochemical analysis, finding an almost complete loss of F4/80 1 cells in the splenic red pulp ( Fig. 2a ). In contrast, SIGN-R1 (also known as CD209a)-expressing marginal zone macrophages and MOMA-1 (also known as Siglec1)-expressing metallophilic marginal zone macrophages were present normally in the spleens of Spic 2/2 mice ( Fig. 2a ). Spic 2/2 mice had normal F4/80 1 tissue macrophages in peritoneum and liver, normal macrophage and dendritic cell progenitors in bone marrow, and normal monocytes in bone marrow and blood ( Supplementary Fig. 6 ).
Loss of RPMs could result either from a cell-autonomous defect or from the loss of a required extrinsic component such as a bone marrow or splenic stromal cell. To distinguish these possibilities, we generated haematopoietic chimaeras by transplanting bone marrow cells from CD45.2 1 Spic 1/1 or Spic 2/2 mice into irradiated congenic CD45. Shown is the normalized messenger RNA expression relative to expression in B cells. b, Spic 1/1 and Spic 2/2 spleen cells were stained with antibodies to F4/80, CD11b, CD68 and CD11c and analysed by flow cytometry. Auto, autofluorescence. Numbers represent the percentage of cells in the indicated gate. c, Frequency of F4/80 hi cells in spleen was determined as the mean (and s.d., n 5 7) from total splenocytes as shown in b. recipients (Fig. 2b ). In these chimaeras, F4/80 1 RPMs developed from Spic 1/1 , but not from Spic 2/2 , donor bone marrow (Fig. 2b ). This defect was restricted to RPMs, because Spic 2/2 donor bone marrow generated normal B cells ( Fig. 2b ), CD11b 1 and CD11c 1 myeloid lineages, natural killer cells and T cells ( Supplementary Fig. 6e ). Development of F4/80 1 RPMs was restored when Spic 2/2 bone marrow was infected with a Spi-C-expressing retrovirus and allowed to develop in lethally irradiated hosts ( Fig. 2c ). These findings indicate that the loss of RPMs in Spic 2/2 mice results from an intrinsic haematopoietic defect.
Senescent red blood cells (RBCs) are normally phagocytosed by macrophages in spleen and liver, followed by degradation of their haemoglobin, and transport of the iron back into the circulation [12] [13] [14] .
To study RBC clearance by splenic macrophages, we used the system of Cd47 2/2 RBCs 13 . We injected carboxy-fluorescein succinimidyl ester (CFSE)-labelled Cd47 2/2 RBCs into mice and examined their clearance and uptake by spleen and liver cells ( Supplementary Fig. 7 ). The initial clearance of Cd47 2/2 RBCs from the circulation was similar between Spic 2/2 and Spic 1/1 mice ( Supplementary Fig.  7a ). However, we found differences in efficiency of phagocytosis of trapped RBCs by splenic macrophages between Spic 1/1 and Spic 2/2 mice. In Spic 1/1 mice, F4/80 hi CD68 1 RPMs showed more than tenfold higher uptake of CFSE than F4/80 lo CD68 1 cells ( Supplementary Fig. 7c, d ). In Spic 2/2 mice, which lacked F4/ 80 hi CD68 1 macrophages ( Supplementary Fig. 7c ), the remaining F4/80 lo CD68 1 macrophages showed the low level of phagocytosis seen in Spic 1/1 mice ( Supplementary Fig. 7d ). Liver cells did not take up labelled Cd47 2/2 RBCs in either wild-type or Spic 2/2 mice ( Supplementary Fig. 7e ). These results suggest that the absence of F4/80 hi RPMs in Spic 2/2 mice represents the loss of a functional macrophage subset that is normally responsible for efficient phagocytosis of RBCs in the spleen.
Spic 2/2 mice developed an age-dependent increase in the size and weight of the spleen not associated with increased numbers of splenocytes ( Fig. 3a, b ). Because mice with genetic defects in iron or haemoglobin metabolism can exhibit splenomegaly 15, 16 , we assessed the iron stores of Spic 2/2 mice. Serum and liver iron concentrations were normal in Spic 2/2 mice, but splenic tissue iron concentration was increased ( Fig. 3c, d and Supplementary Fig. 8a, b ). This iron accumulation was evident histologically in Spic 2/2 mice and largely confined to the red pulp ( Fig. 3e and Supplementary Figs 8c and 9a), but was not observed in the liver or intestine ( Supplementary Fig. 8d , and data not shown). Spic 2/2 mice did not exhibit abnormal erythroid parameters or morphology (Supplementary Table 2 and Supplementary Fig. 9c ).
To identify potential Spi-C target genes, we compared global gene expression profiles of RPMs, alveolar and peritoneal macrophages, monocytes and dendritic cells (Fig. 4a ). The haemoglobin scavenger receptor (Cd163) 17 and the iron transporter ferroportin 1 (Slc40a1) 18 were both highly expressed by RPMs relative to other macrophage subsets or B cells (Fig. 4a ). Vascular cell adhesion molecule 1 (Vcam1) was also highly expressed in RPMs compared to peritoneal and alveolar macrophages (Fig. 4a) , consistent with reported Vcam1 expression in the red pulp 19, 20 . Vcam1 is most highly expressed in the red pulp of control spleens, but was virtually absent in Spic 2/2 spleens (Fig. 4b, Supplementary 10a, b) . In Spic 1/1 spleens, Vcam1 was highly correlated with F4/80 expression ( Supplementary Fig. 10a ), both of which were substantially reduced in Spic 2/2 spleens. In contrast, other tissues did not show this coordinated expression of F4/80 and Vcam1 ( Supplementary Fig. 10a ). Peritoneal macrophages expressed high F4/80 without high Vcam1, and most F4/80 1 cells in lymph nodes expressed low levels of Vcam1 ( Supplementary Fig.  10b ). However, Vcam1 expression by B cells was reduced in Spic 2/2 mice compared to Spic 1/1 mice ( Supplementary Fig. 10b ). Bone marrow monocytes treated with M-CSF (colony stimulating factor 1, also known as Csf1) 21 induced both Spi-C and Vcam1 expression, whereas treatment with GM-CSF (also known as Csf2) caused much less induction of Spi-C and no induction of Vcam1 ( Supplementary  Fig. 10c ). Consistently, Spic 2/2 bone marrow cells treated with M-CSF showed reduced levels of Vcam1 expression compared to wild-type cells ( Supplementary Fig. 10d ). Together, these results suggest the possibility that Spi-C may regulate the expression of Vcam1.
Reporter analysis and electrophoretic mobility shift assays (EMSAs) provide additional evidence that Spi-C regulates Vcam1 ( Fig. 4c-e ). PU.1 can augment FccR2b promoter activity 22 . PU.1 and Spi-C each augment a Vcam1 reporter by a similar magnitude 22 (Fig. 4c ). An Ets consensus element within the proximal Vcam1 promoter forms complexes with PU.1 and Spi-C in EMSAs (Fig. 4d ), which are supershifted by anti-PU.1 or anti-Spi-C antisera, respectively (Fig. 4e ). Formation of the Spi-C EMSA complex was specifically inhibited by an FccR2b Ets probe and Vcam1 Ets probe, but not by a mutated Vcam1 Ets probe. Deletion of the Ets element within the Vcam1 promoter eliminated reporter augmentation by both PU.1 and Spi-C ( Fig. 4c ). To test whether Spi-C could induce b c Vcam1 in cell lines, we transfected the RAW264.7 macrophage cell line with Spi-C retrovirus (Spi-C-RV) or control retrovirus ( Supplementary Fig. 10e ). Control RAW264.7 cells do not express Spi-C or Vcam1, and treatment with M-CSF only weakly induced Vcam1. In Spi-C-expressing RAW264.7 cells, M-CSF strongly induced Vcam1, but not CD163, ferroportin, haem oxygenase or Mon1a. Thus, Vcam1 seems to be a target of Spi-C in macrophages. Spi-C was initially identified as a PU.1-related transcription factor expressed in B cells, but its function was unknown 5, 7 . An earlier report based on overexpression studies suggested Spi-C might regulate immunoglobulin E production 23 . Differential expression of Spi-C was suggested as evidence for independent ontogeny for splenic B cells and peritoneal B1a B cells 24 . We find Spic 2/2 mice to have normal B-cell development and antibody production, but do not exclude a subtle role for Spi-C in B-cell function. However, our evidence supports a critical role for Spi-C in the development of RPMs, and shows that this cell lineage is required for normal recycling of red blood cells and iron homeostasis in the spleen.
The known genetic defects of iron metabolism 14, 25, 26 frequently involve proteins that function as iron transporters/exporters (for example, ferroportin 18 ), as receptors for iron-binding proteins (for example, transferrin receptor 27 and hemochtomatosis 28 ), or to regulate the activity of these transporters or receptors (for example, hepcidin 29 ). Such gene defects that directly alter iron transport can produce global changes in iron storage that may affect many tissues. In contrast, the transcription factor Spi-C is the first gene to affect iron metabolism by controlling the development of a particular cell lineage important for recycling red blood cells and their products. Future studies will be directed at analysis of the specific roles of transcriptional targets of Spi-C, such as Vcam1, in elaborating these functions of red pulp macrophages.
METHODS SUMMARY
Mice and reagents. Spic 2/2 mice were generated by deleting the entire proteincoding regions exons 2-6 of the Spic locus. The neomycin resistance cassette was deleted by intercrossing Spic 1/2 mice with CMV-Cre deletor mice to produce Spic null/null mice, as described in Supplementary Methods. Histochemical analysis. Six-micrometre frozen tissue sections were fixed in cold acetone and blocked with 5% bovine serum albumin (Roche). The monoclonal antibodies used were biotinylated antibody against F4/80 (Caltag), Vcam1 (eBioscience), MOMA-1 (BMA Biomedicals) and SIGN-R1 (ER-TR9, BMA 
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Comp: Spic 1/1 and Spic 2/2 mice of the indicated age were weighed (n 5 3 per time point). Representative spleens at 32 weeks are shown in the inset. b, Splenocytes from Spic 1/1 and Spic 2/2 mice were counted (mean and s.d., n 5 5). c, Iron levels in spleen (left) and liver (right) of 129 SvEv background Spic 1/1 and Spic 2/2 male mice on a standard diet (mean and s.d., n 5 4). d, Serum iron levels were determined for 32-week-old 129 SvEv background Spic 1/1 and Spic 2/2 male mice on a standard diet. e, Perl's Prussian blue stain for ferric iron in the spleens of 16-week old 129 SvEv Spic 1/1 and Spic 2/2 male mice. Biomedicals), Alexa488-conjugated antibody against B220 (BD PharMingen) and streptavadin-Alexa555 (Invitrogen). For Perl's Prussian blue stain, tissues were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.0), embedded in paraffin, and stained with Perl's Prussian blue and pararosaniline (Sigma). Adoptive transfer of bone marrow cells. Recipient CD45.1 1 B6.SJL (Taconic) mice were lethally irradiated with 1,100 rads and injected intravenously with 10 7 bone marrow cells obtained from CD45.2 1 F4 or F5 Spic 1/1 or Spic 2/2 mice. Donor-derived cells in spleen (CD45.2 1 ) were analysed 10 weeks after transfer by fluorescence-activated cell sorting. Measurement of iron content in spleen, liver and serum. Age-and gendermatched mice were analysed for non-haem iron as described 30 . Livers and spleens were weighed and digested in 3 M hydrochloric acid/10% trichloroacetic acid, at 65 uC for 20 h. Ten microlitres of each acid extract was mixed with 0.5 ml of chromagen reagent. The absorbance at 535 nm was measured by a DU Series 500 spectrophotometer (Beckman), and compared to an iron standard treated identically. For serum measurements 30 , 20 ml of serum was incubated with 20 ml of acid reagent for 5 min. Supernatant was mixed with 40 ml chromagen reagent, and absorbance at 535 nm was measured as described above.
